معرفی
Else Skovgaard Holmfred is a Postdoctoral Researcher at Stanford University's Department of Pharmacy within the School of Medicine. She specializes in advanced analytical chemistry applications in pharmaceutical science, with expertise in ICP-MS, mass spectrometry, HPLC, DLS, and multivariate data analysis. Her work focuses on developing innovative pharmaceutical methodologies using isotopic and trace elemental analysis to detect non-visual drug counterfeits.
Her educational background includes:
- Ph.D. in Pharmaceutical Sciences from Technical University of Denmark (2018-2022)
- M.Sc. in Pharmaceutical Sciences from University of Copenhagen (2015-2017)
- B.Sc. in Pharmacy from University of Copenhagen (2011-2014)
Dr. Holmfred's research integrates biogeochemistry with pharmaceutical science to create novel approaches for drug authentication. Her work spans isotopic analysis of pharmaceutical products, trace element fingerprinting, nanomaterial characterization, and pharmaceutical excipient studies. She employs sophisticated analytical techniques to address critical issues in drug quality and safety, with particular emphasis on detecting counterfeit medications that cannot be identified through visual inspection.
Her publication record demonstrates consistent output in high-impact journals, showing a clear trajectory from nanomaterial dissolution studies toward increasingly sophisticated pharmaceutical authentication methods. Recent work focuses on isotopic patterns in drug products (2025), trace element analysis in ibuprofen (2024), and protein compaction properties (2024), reflecting her evolving expertise at the intersection of analytical chemistry and pharmaceutical science.
Scientific recognition includes:
- Carlsberg Foundation Internationalisation Fellowship (2022)
- Novo Nordisk Foundation Visiting Scholar Stanford Bio-X Fellowship (2023)
Her research has garnered significant attention, being picked up by 10 news outlets, referenced in policy sources, and blogged about extensively. She conducts her research in the Chamberlain lab at Stanford University, where she applies biogeochemical approaches to pharmaceutical challenges. Her work has practical implications for drug safety and quality control, with potential applications in regulatory science and pharmaceutical manufacturing.
